The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson’s disease

Nature Biotechnology, Published online: 02 May 2025; doi:10.1038/s41587-025-02567-2

Patients with Parkinson’s disease treated with fetal tissue are assessed 3 years after surgery.

​Nature Biotechnology, Published online: 02 May 2025; doi:10.1038/s41587-025-02567-2Patients with Parkinson’s disease treated with fetal tissue are assessed 3 years after surgery. Read More